1. Home
  2. MNDO vs PASG Comparison

MNDO vs PASG Comparison

Compare MNDO & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.07

Market Cap

19.0M

Sector

Technology

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$4.55

Market Cap

19.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDO
PASG
Founded
1995
2017
Country
Israel
United States
Employees
N/A
27
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
19.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
MNDO
PASG
Price
$1.07
$4.55
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
52.7K
90.5K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
20.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$3.29
52 Week High
$1.50
$20.00

Technical Indicators

Market Signals
Indicator
MNDO
PASG
Relative Strength Index (RSI) 65.69 41.77
Support Level $1.02 $3.94
Resistance Level $1.24 $6.01
Average True Range (ATR) 0.04 0.53
MACD 0.01 -0.08
Stochastic Oscillator 89.48 46.18

Price Performance

Historical Comparison
MNDO
PASG

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: